“The MBI blueprint for funding cures for rare diseases is replicable and likely to disrupt the standard way health care research is funded and carried out by radically shortening the timeline.”
MBI has been highlighted by one of the most prestigious institutions in the world, MIT – Massachusetts Institute of Technology. An article showcasing our innovative model and its pioneering advances is available on the MIT website. This recognition reaffirms the significance of the work we are doing and inspires us to continue making a difference.
